cas 59107-51-6|| where to buy 8-chloronaphthalen-1-amine

Nom du produit:8-chloronaphthalen-1-amine

IUPAC Name:8-chloronaphthalen-1-amine

Unité d'emballage	Stock disponible	Prix($)
CM141452-25g	in stock	ȦȷȦ
CM141452-100g	in stock	ȌƋƋ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 59107-51-6 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:59107-51-6; Formule moléculaire:C10H8ClN; Point de fusion:-; Code SMILES:ClC1=CC=CC2=CC=CC(N)=C12; Densité:

: Numéro de catalogue:CM141452; Poids moléculaire:177.63; Point d'ébullition:; N° Mdl:MFCD00465087; Stockage:Keep in a tight container nitrogen protection，and store at ambient temperature，protect from light

: Naphthalenes; Naphthalene is a hydrocarbon produced by the distillation of coal tar and is an aromatic white crystalline substance. Naphthalene is the most abundant component in coal tar. It is used as an insect repellant and insect fumigant. The compound is used in the manufacture of celluloid, dyes, hydrogenated naphthalenes, oil fumes, smokeless powders and synthetic resins.

: Adagrasib; Jan. 10, 2024, EC approves KRAZATI (adagrasib) as a targeted treatment option for patients with advanced non-small cell lung cancer (NSCLC) with a KRAS G12C mutation.
Adagrasib is an orally available, potent, irreversible, small molecule inhibitor of KRAS G12C mutant isoform for the treatment of solid tumours harbouring KRAS G12C oncogenic driver mutation. Adagrasib covalently binds to the mutant cysteine in KRAS G12C and locks the mutant KRAS protein in its inactive state, thereby preventing downstream signalling without affecting wild-type KRAS protein.